118 related articles for article (PubMed ID: 21243595)
1. [New treatment option for women with chronic constipation - prucalopride stimulates the disturbed gut motility again].
Z Gastroenterol; 2011 Jan; 49(1):e1-2. PubMed ID: 21243595
[No Abstract] [Full Text] [Related]
2. Prucalopride: a new drug for the treatment of chronic constipation.
Tack J
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
[No Abstract] [Full Text] [Related]
4. Motility: prucalopride for chronic constipation.
Bassotti G; Villanacci V
Nat Rev Gastroenterol Hepatol; 2009 Jun; 6(6):324-5. PubMed ID: 19494821
[No Abstract] [Full Text] [Related]
5. Prucalopride succinate for the treatment of constipation: an update.
Bassotti G; Gambaccini D; Bellini M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
[TBL] [Abstract][Full Text] [Related]
6. The use of Resolor (prucalopride) for chronic constipation in women.
Woodward S
Br J Nurs; 2012 Sep 13-26; 21(16):982, 984-6. PubMed ID: 23123655
[TBL] [Abstract][Full Text] [Related]
7. Use of prucalopride in adults with chronic idiopathic constipation.
Vijayvargiya P; Camilleri M
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of prucalopride in adults and children with chronic constipation.
Diederen K; Mugie SM; Benninga MA
Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
[TBL] [Abstract][Full Text] [Related]
9. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
Bassotti G; Usai Satta P; Bellini M
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
[TBL] [Abstract][Full Text] [Related]
10. Prucalopride. In chronic constipation: poorly documented risks.
Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
[TBL] [Abstract][Full Text] [Related]
11. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
Tack J; Corsetti M
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
[TBL] [Abstract][Full Text] [Related]
12. Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride.
Boeckxstaens GE; Bartelsman JF; Lauwers L; Tytgat GN
Am J Gastroenterol; 2002 Jan; 97(1):194-7. PubMed ID: 11811166
[TBL] [Abstract][Full Text] [Related]
13. [Distinguished award for the prokinetic drug prucalopride].
Wedekind S
MMW Fortschr Med; 2015 Apr; 157(6):10-1. PubMed ID: 26015178
[No Abstract] [Full Text] [Related]
14. Prucalopride for constipation.
Camilleri M; Deiteren A
Expert Opin Pharmacother; 2010 Feb; 11(3):451-61. PubMed ID: 20102308
[TBL] [Abstract][Full Text] [Related]
15. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
Dubois D; Gilet H; Viala-Danten M; Tack J
Neurogastroenterol Motil; 2010 Feb; 22(2):e54-63. PubMed ID: 19761492
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation.
Müller-Lissner S; Rykx A; Kerstens R; Vandeplassche L
Neurogastroenterol Motil; 2010 Sep; 22(9):991-8, e255. PubMed ID: 20529205
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
[TBL] [Abstract][Full Text] [Related]
18. [Cisapride--a new drug effective in the treatment of disorders of gastrointestinal motility].
Kasicka A; Jonderko K
Przegl Lek; 1989; 46(3):356-9. PubMed ID: 2672116
[No Abstract] [Full Text] [Related]
19. [Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].
Osipenko MF; Bikbulatova EA; Skalinskaia MA; Kulygina IuA; Pankova LIu
Ter Arkh; 2013; 85(12):60-4. PubMed ID: 24640670
[TBL] [Abstract][Full Text] [Related]
20. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation.
Bassotti G; Chiarioni G; Vantini I; Morelli A; Whitehead WE
Z Gastroenterol; 1998 Mar; 36(3):209-13. PubMed ID: 9577904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
